Syschem India Limited has announced that promoter Ranjan Jain has sold a portion of his shareholding through open market transactions. The disclosure was submitted to BSE Limited on February 14, 2026, in compliance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Transaction Details

The share sale transaction involved the disposal of 1,60,000 equity shares through open market operations conducted between February 11-13, 2026. The following table summarizes the key transaction parameters:

Shareholding Pattern Changes

The transaction resulted in a reduction of Ranjan Jain's stake in Syschem India Limited. His shareholding position before and after the sale is detailed below:

Company Capital Structure

Syschem India Limited's equity share capital structure remains unchanged following the promoter's share sale:

• Total Equity Share Capital: Rs. 43.51 crores • Number of Equity Shares: 4,35,13,000 shares • Face Value per Share: Rs. 10 • Total Diluted Share Capital: Rs. 56.56 crores (56,56,3000 shares)

Regulatory Compliance

The disclosure was made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Ranjan Jain, who serves as both Promoter and Director of the company, submitted the required documentation to BSE Limited where Syschem India's shares are listed. The transaction involved only shares carrying voting rights, with no encumbrances, warrants, or convertible securities involved in the sale.

The promoter confirmed that he belongs to the Promoter Group and that all regulatory requirements have been fulfilled in connection with this share disposal transaction.

Syschem India Limited has delivered exceptional financial performance in the nine months of FY25-26, demonstrating strong growth across all key metrics. The pharmaceutical API manufacturer presented comprehensive results showcasing significant improvements in revenue, profitability, and market expansion.

Financial Performance Highlights

The company achieved remarkable growth in 9M FY25-26 compared to the corresponding period in the previous year. Revenue from operations surged by 65%, rising from ₹24,748 lakhs in 9M FY24-25 to ₹40,631 lakhs in 9M FY25-26.

Quarterly Performance Analysis

The third quarter of FY25-26 marked exceptional performance with strong year-on-year improvements. Q3 FY25-26 revenue reached ₹16,164 lakhs compared to ₹9,112.60 lakhs in Q3 FY24-25, representing a 177% increase.

Market Expansion and Sales Performance

Syschem India Limited demonstrated robust performance across both domestic and export markets. Export sales reached ₹107.62 crore in 9M FY25-26, surpassing the full-year FY24-25 exports of ₹90.89 crore. Domestic sales also showed growth, rising to ₹247.83 crore in 9M FY25-26 compared to ₹241.25 crore in FY24-25.

The Q3 performance was particularly strong with export sales surging from ₹26.16 crores in Q3 FY24-25 to ₹53.99 crores in Q3 FY25-26, registering a 106% increase. Domestic sales rose from ₹51.84 crores to ₹87.97 crores, reflecting approximately 70% growth.

Operational Infrastructure and Capacity

The company operates with significant operational capabilities including an installed capacity of approximately 4,200 TPA across a 6-acre land bank area. Syschem serves over 100 consumers and traders globally with 7+ API SKUs and maintains a global footprint across 3 continents and 10+ countries.

Product Portfolio and Market Position

The company manufactures various pharmaceutical APIs including Amoxicillin, Ampicillin, Flucloxacillin, Cloxacillin, Cephalexin, and Cephadroxil. These antibiotics belong to the penicillin and cephalosporin families, serving critical healthcare needs in domestic and international markets.

Corporate Structure and Leadership

Syschem India Limited, incorporated on December 31, 1993, is led by an experienced management team. The shareholding pattern as of December 31, 2025, shows promoter and promoter group holding 56.71% while public shareholding stands at 43.29%. The company is listed on BSE with scrip code 531173 and NSE symbol SYSCHEM, with issued shares of 4,35,13,000.